BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23643507)

  • 1. Evaluation of the new CE-IVD marked BD MAX Cdiff Assay for the detection of toxigenic Clostridium difficile harboring the tcdB gene from clinical stool samples.
    Verhoeven PO; Carricajo A; Pillet S; Ros A; Fonsale N; Botelho-Nevers E; Lucht F; Berthelot P; Pozzetto B; Grattard F
    J Microbiol Methods; 2013 Jul; 94(1):58-60. PubMed ID: 23643507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile.
    Viala C; Le Monnier A; Maataoui N; Rousseau C; Collignon A; Poilane I
    J Microbiol Methods; 2012 Aug; 90(2):83-5. PubMed ID: 22565213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance assessment of the BD MAX Cdiff assay in comparison to Xpert C. difficile assay in a setting with very low prevalence of toxigenic Clostridium difficile PCR ribotype 027.
    Chiang D; Ng S; La MV; Jureen R; Lin RT; Teo JW
    Anaerobe; 2014 Dec; 30():156-8. PubMed ID: 25305151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Verigene Clostridium difficile, Simplexa C. difficile Universal Direct, BD MAX Cdiff, and Xpert C. difficile assays for the detection of toxigenic C. difficile.
    Gilbreath JJ; Verma P; Abbott AN; Butler-Wu SM
    Diagn Microbiol Infect Dis; 2014 Sep; 80(1):13-8. PubMed ID: 25027069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Xpert C. difficile, BD MAX Cdiff, IMDx C. difficile for Abbott m2000, and Illumigene C. difficile Assays for Direct Detection of Toxigenic Clostridium difficile in Stool Specimens.
    Shin BM; Yoo SM; Shin WC
    Ann Lab Med; 2016 Mar; 36(2):131-7. PubMed ID: 26709260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a new molecular test, the BD Max Cdiff, for detection of toxigenic Clostridium difficile in fecal samples.
    Le Guern R; Herwegh S; Grandbastien B; Courcol R; Wallet F
    J Clin Microbiol; 2012 Sep; 50(9):3089-90. PubMed ID: 22760042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of 3 automated real-time PCR (Xpert C. difficile assay, BD MAX Cdiff, and IMDx C. difficile for Abbott m2000 assay) for detecting Clostridium difficile toxin gene compared to toxigenic culture in stool specimens.
    Yoo J; Lee H; Park KG; Lee GD; Park YG; Park YJ
    Diagn Microbiol Infect Dis; 2015 Sep; 83(1):7-10. PubMed ID: 26081240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the fully automated BD MAX Cdiff and Xpert C. difficile assays for direct detection of Clostridium difficile in stool specimens.
    Dalpke AH; Hofko M; Zorn M; Zimmermann S
    J Clin Microbiol; 2013 Jun; 51(6):1906-8. PubMed ID: 23515539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the BD MAX Cdiff assay for the detection of the toxin B gene of Clostridium difficile out of faecal specimens.
    Leitner E; Einetter M; Grisold AJ; Marth E; Feierl G
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):390-1. PubMed ID: 23602785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of BD Max Cdiff and GenomEra C. difficile molecular assays for detection of toxigenic Clostridium difficile from stools in conventional sample containers and in FecalSwabs.
    Hirvonen JJ; Kaukoranta SS
    Eur J Clin Microbiol Infect Dis; 2015 May; 34(5):1005-9. PubMed ID: 25616552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the BD Max Cdiff assay for the detection of toxigenic Clostridium difficile in human stool specimens.
    Putsathit P; Morgan J; Bradford D; Engelhardt N; Riley TV
    Pathology; 2015 Feb; 47(2):165-8. PubMed ID: 25551308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the illumigene C. difficile assay for toxigenic Clostridium difficile detection: a prospective study of 302 consecutive clinical fecal samples.
    Hong G; Park KS; Ki CS; Lee NY
    Diagn Microbiol Infect Dis; 2014 Nov; 80(3):177-80. PubMed ID: 25241189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of BD GeneOhm Cdiff and Seegene Seeplex ACE PCR assays using toxigenic Clostridium difficile culture for direct detection of tcdB from stool specimens.
    Shin BM; Mun SJ; Yoo SJ; Kuak EY
    J Clin Microbiol; 2012 Nov; 50(11):3765-7. PubMed ID: 22952270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of the Meridian Illumigene™ loop-mediated amplification assay and the Gen Probe ProGastro™ Cd polymerase chain reaction assay for the direct detection of toxigenic Clostridium difficile from fecal samples.
    Doing KM; Hintz MS
    Diagn Microbiol Infect Dis; 2012 Jan; 72(1):8-13. PubMed ID: 22015321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of a non-purified direct molecular assay for the detection of Clostridioides difficile toxin genes in stool specimens.
    Hara T; Suzuki H; Oyanagi T; Koyanagi N; Ushiki A; Kawabata N; Goto M; Hida Y; Yaguchi Y; Tamai K; Notake S; Kawashima Y; Sugiyama A; Uemura K; Kashiyama S; Nanmoku T; Suzuki S; Yamazaki H; Kimura H; Kunishima H; Ohge H
    PLoS One; 2020; 15(6):e0234119. PubMed ID: 32492051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel portable platform for molecular detection of toxigenic Clostridium difficile in faeces: a diagnostic accuracy study.
    Hirvonen JJ; Matero P; Siebert C; Kauppila J; Vuento R; Tuokko H; Boisset S
    Eur J Clin Microbiol Infect Dis; 2017 May; 36(5):783-789. PubMed ID: 27988815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the cobas Cdiff Test for Detection of Toxigenic Clostridium difficile in Stool Samples.
    Peterson LR; Young SA; Davis TE; Wang ZX; Duncan J; Noutsios C; Liesenfeld O; Osiecki JC; Lewinski MA
    J Clin Microbiol; 2017 Dec; 55(12):3426-3436. PubMed ID: 28954901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of different methods to detect Clostridium difficile infection.
    Calderaro A; Buttrini M; Martinelli M; Gorrini C; Montecchini S; Medici MC; Arcangeletti MC; De Conto F; Covan S; Chezzi C
    New Microbiol; 2013 Jan; 36(1):57-63. PubMed ID: 23435816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance Evaluation of the Luminex Aries C. difficile Assay in Comparison to Two Other Molecular Assays within a Multihospital Health Care Center.
    Juretschko S; Manji R; Khare R; Das S; Dunbar S
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31413082
    [No Abstract]   [Full Text] [Related]  

  • 20. Laboratory diagnosis of Clostridium difficile associated diarrhoea and molecular characterization of clinical isolates.
    Russello G; Russo A; Sisto F; Scaltrito MM; Farina C
    New Microbiol; 2012 Jul; 35(3):307-16. PubMed ID: 22842600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.